Frontline Management of Atopic Dermatitis in Adults : Episode 7

Opinion

Video

March 3, 2025

The Impact of Biologics on a Changing Atopic Dermatitis Treatment Landscape

Author(s):

Brad P. Glick, DO, MPH,Zed Zha, MD, FAAFP

Panelists discuss how the emergence of targeted biologics has revolutionized atopic dermatitis treatment by offering effective alternatives to traditional therapies. These agents, including IL-4/IL-13 inhibitors like dupilumab and others targeting specific inflammatory pathways, have provided new options for moderate to severe cases resistant to conventional treatments.

EP: 1.Frontline Management of Atopic Dermatitis in Adults

EP: 2.Considerations for Diagnosis of Atopic Dermatitis in Adults

EP: 3.A Primary Care Perspective on Diagnosing Atopic Dermatitis

EP: 4.Strategies for Determining Severity of Atopic Dermatitis

EP: 5.Collaboration Between Primary Care and Dermatology in Atopic Dermatitis Care

EP: 6.The Utility of Newer Topical Therapies for Atopic Dermatitis

EP: 7.The Impact of Biologics on a Changing Atopic Dermatitis Treatment Landscape

Video content above in prompted by the following:

How has the development and approval of several biologics changed the treatment spectrum for atopic dermatitis?

Related Videos

3 experts are featured in this series.

5 experts in this video

Achieving Chronic Spontaneous and Inducible Urticaria Control With Barzolvolimab, with Martin Metz, MD

Scott Commins, MD, PhD I Credit: UNC School of Medicine

Optimizing ISM Treatment Beyond Approval, with Vito Sabato, MBBS

Updated Treatment Strategies for Pediatric Atopic Dermatitis in 2025, with Ama Alexis, MD

Exciting Therapies on the Horizon for Atopic Dermatitis, with Raj Chovatiya, MD, PhD

Faradia Kernizan: Exploring Pediatric Dermatology, Unmet Needs, Mentorship

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.